Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cantaloupe (CTLPP) Cash & Equivalents (2016 - 2026)

Cantaloupe has reported Cash & Equivalents over the past 16 years, most recently at $53.0 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 91.41% to $53.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.0 million through Dec 2025, up 91.41% year-over-year, with the annual reading at $51.1 million for FY2025, 13.19% down from the prior year.
  • Cash & Equivalents was $53.0 million for Q4 2025 at Cantaloupe, down from $55.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $88.6 million in Q1 2021 and troughed at $27.7 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $52.1 million (2025), against an average of $56.4 million.
  • Year-over-year, Cash & Equivalents surged 242.02% in 2021 and then crashed 63.12% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $76.3 million in 2021, then plummeted by 63.12% to $28.1 million in 2022, then surged by 54.49% to $43.5 million in 2023, then crashed by 36.34% to $27.7 million in 2024, then soared by 91.41% to $53.0 million in 2025.
  • Per Business Quant, the three most recent readings for CTLPP's Cash & Equivalents are $53.0 million (Q4 2025), $55.0 million (Q3 2025), and $51.1 million (Q2 2025).